Flag of the European Union EU Clinical Trials Register Help

Clinical trials for Proximal subungual onychomycosis

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

    • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).

    The EU Clinical Trials Register currently displays   44344   clinical trials with a EudraCT protocol, of which   7373   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    6 result(s) found for: Proximal subungual onychomycosis. Displaying page 1 of 1.
    EudraCT Number: 2006-000974-54 Sponsor Protocol Number: RD.03.SPR.40026 Start Date*: 2007-02-28
    Sponsor Name:GALDERMA Research & Development
    Full Title: A multi-centre, randomized, parallel groups, vehicle and active controlled study of amorolfine 4% and 10% nail lacquer new formulation in the topical treatment of distal and lateral subungual toena...
    Medical condition: Distal and lateral subungual onychomycosis
    Disease: Version SOC Term Classification Code Term Level
    8.1 10030338 LLT
    Population Age: Adults Gender: Male, Female
    Trial protocol: IS (Completed) CZ (Completed) DE (Completed)
    Trial results: View results
    EudraCT Number: 2008-002418-23 Sponsor Protocol Number: W0027-10 Start Date*: 2008-12-17
    Sponsor Name:Stiefel Laboratories Inc.
    Full Title: A phase 2, randomized, double-blind, placebo-controlled, parallel-group, dose-ranging study to investigate the efficacy and safety of 4 dose regimens of oral albaconazole in subjects with distal su...
    Medical condition: Distal subungual onychomycosis
    Disease: Version SOC Term Classification Code Term Level
    8.1 10030338 Onychomycosis PT
    9.1 10030338 Onychomycosis LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: IS (Completed)
    Trial results: (No results available)
    EudraCT Number: 2009-011125-14 Sponsor Protocol Number: RV4104A-2008-548 Start Date*: 2009-07-06
    Sponsor Name:Pierre Fabre Dermatologie
    Full Title: A multicentre, randomized, controlled study of the efficacy, safety and cost-effectiveness of a sequential therapy with RV4104A ointment, ciclopiroxolamine cream and ciclopirox film-forming solutio...
    Medical condition: Patients suffering from distal-lateral or lateral subungual onychomycosis of one great toenail (the target nail) without matrix involvement
    Disease: Version SOC Term Classification Code Term Level
    9.1 10030338 Onychomycosis LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: FR (Completed)
    Trial results: View results
    EudraCT Number: 2007-004331-27 Sponsor Protocol Number: P05205 Start Date*: 2008-12-23
    Sponsor Name:Schering-Plough Research Institute, a Division of Schering Corporation
    Full Title: A Randomized, Double-Blind, Vehicle-Controlled, Multicenter Study to Evaluate the Safety and Efficacy of SCH 900340 5% Solution Compared with Vehicle Administered Topically in the Treatment of Dist...
    Medical condition: Onychomycosis
    Disease: Version SOC Term Classification Code Term Level
    9.1 10030338 Onychomycosis LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Prematurely Ended) IS (Prematurely Ended) BE (Completed) SE (Prematurely Ended) ES (Prematurely Ended) GB (Prematurely Ended) BG (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2022-001797-59 Sponsor Protocol Number: MOB015B-44-21-002 Start Date*: 2023-06-12
    Sponsor Name:Moberg Pharma AB
    Full Title: A multi-center, single-arm, open-label study to evaluate tolerability, safety, and efficacy of topical MOB015B solution in the treatment of mild to moderate distal subungual onychomycosis (DSO) in ...
    Medical condition: Distal Subungual Onychomycosis
    Disease:
    Population Age: Children, Adolescents, Under 18 Gender: Male, Female
    Trial protocol: IT (Trial now transitioned) DK (Trial now transitioned) PL (Trial now transitioned) IS (Trial now transitioned)
    Trial results: (No results available)
    EudraCT Number: 2006-006338-17 Sponsor Protocol Number: CL-067-II-01 Start Date*: 2007-08-22
    Sponsor Name:CPDS BERMUDA, LTD.
    Full Title: OPEN-LABEL STUDY OF EFFICACY AND SAFETY OF 067 (TERBINAFINE IN TRANSFERSOME®) FOR THE TREATMENT OF ONYCHOMYCOSIS
    Medical condition: Bilateral onychomycosis of the hallux nail (great toe) with positive mycosis culture and KOH microscopy as per central laboratory, otherwise healthy according to physical examination
    Disease: Version SOC Term Classification Code Term Level
    9.1 10030338 Onychomycosis PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: (No results available)
    Download Options:
    Number of Trials to download:
    Download Content:
    Download Format:
    Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.
    Query did not match any studies.
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Tue Jun 24 11:20:02 CEST 2025 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA